Exactics
PrivateLast Round
Seed
Nov 21, 2025
Total Funding Raised
$1.88M
Momentum Score
25 /100
Company Overview
Exactics, Inc. is a biotechnology company focused on developing affordable, accurate, and accessible at-home rapid diagnostic tools for infectious diseases. The company's mission is to make early detection a standard in healthcare, thereby preventing the severe effects of diseases that could be avoided with timely diagnosis. Exactics was founded in 2021 by a team from the University of Chicago. Its proprietary technology is an adaptable diagnostics platform for creating competitive lateral flow assays (cLFAs) for over 200 infectious diseases, with its principal product being an at-home rapid test for Lyme disease. The platform is designed to significantly reduce R&D costs and development time.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exactics Comps
Public and private peers based on sector, stage, and business model.
Exactics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 21, 2025 | ||||
| Grant | May 29, 2025 | ||||
| Grant | Apr 18, 2025 | ||||
| Accelerator | Mar 10, 2025 | ||||
| Grant | Mar 10, 2025 |
Exactics Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2026
Attended the 2026 Tulane Business Model Competition.
- Mar 11, 2026
Won Grand Prize in the 2026 Tulane Business Model Competition.
Exactics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Exactics's valuation, stock price, and market status.
